FDA Nominee Dodges Tough Questions as Agency Faces Crisis of Confidence

Heidi Overton, President Trump's nominee to lead the FDA, spent two hours before the Senate HELP Committee on Thursday carefully avoiding her own views on the issues that matter most. When pressed on whether the abortion drug mifepristone is safe, she agreed only with "the statutory standards of safety and efficacy" rather than offering her own assessment. On vaccines, she affirmed that every FDA-approved shot is "safe and effective" — but critics note she didn't...